Apyx Medical (APYX) Income from Non-Controlling Interests (2013 - 2026)
Apyx Medical (APYX) posted Income from Non-Controlling Interests of -$35000.0 for Q1 2026, down 159.32% on a QoQ basis from $59000.0 in Q4 2025, and down 59.09% year-over-year from -$85555.6 in Q1 2025.
Apyx Medical (APYX) Income from Non-Controlling Interests (2013 - 2026) Analysis & Trends
Apyx Medical's Income from Non-Controlling Interests history runs 10 years deep, the most recent figure standing at -$35000.0 for Q1 2026.
- Quarterly Income from Non-Controlling Interests fell 59.09% year-over-year to -$35000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $93000.0 (up 189.42% YoY) and the FY2025 annual result came in at $106000.0, up 210.42% from the prior year.
- Income from Non-Controlling Interests was -$35000.0 for Q1 2026 at Apyx Medical, down from $59000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at $59000.0 in Q4 2025 and bottomed at -$49000.0 in Q1 2023.
- A 5-year average of -$15058.8 and a median of -$23000.0 in 2022 frame the typical range for Income from Non-Controlling Interests.
- Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests tumbled 475.0% — and 2025, when it surged 290.32%.
- Apyx Medical's Income from Non-Controlling Interests stood at -$16000.0 in 2022, then fell by 6.25% to -$17000.0 in 2023, then tumbled by 82.35% to -$31000.0 in 2024, then jumped by 290.32% to $59000.0 in 2025, then sank by 159.32% to -$35000.0 in 2026.
- Business Quant data shows APYX's Income from Non-Controlling Interests at -$35000.0 in Q1 2026, $59000.0 in Q4 2025, and $29000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -5.85 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Apyx Medical | 167.53 Mn | 136.65 Mn | 7.93 Mn | -35,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35,000.00 |
| Dec 31, 2025 | 59,000.00 |
| Sep 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Mar 31, 2025 | -22,000.00 |
| Dec 31, 2024 | -31,000.00 |
| Sep 30, 2024 | -21,000.00 |
| Jun 30, 2024 | -30,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Dec 31, 2023 | -17,000.00 |
| Sep 30, 2023 | -46,000.00 |
| Jun 30, 2023 | -25,000.00 |
| Mar 31, 2023 | -49,000.00 |
| Dec 31, 2022 | -16,000.00 |
| Sep 30, 2022 | -31,000.00 |
| Jun 30, 2022 | -24,000.00 |
| Mar 31, 2022 | -23,000.00 |
| Dec 31, 2021 | -7,000.00 |
| Sep 30, 2021 | -12,000.00 |
| Jun 30, 2021 | -5,000.00 |